- Home
- TNGX vs LOB Comparison
TNGX vs LOB Comparison
Compare TNGX & LOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TNGX | LOB |
|---|---|---|
| Founded | 2014 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | TNGX | LOB |
|---|---|---|
| Price | $9.11 | $34.24 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 3 |
| Target Price | $12.50 | ★ $40.00 |
| AVG Volume (30 Days) | ★ 2.8M | 260.7K |
| Earning Date | 11-04-2025 | 01-21-2026 |
| Dividend Yield | N/A | ★ 0.36% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.49 |
| Revenue | $66,501,000.00 | ★ $434,209,000.00 |
| Revenue This Year | $53.01 | $44.86 |
| Revenue Next Year | N/A | $16.20 |
| P/E Ratio | ★ N/A | $22.32 |
| Revenue Growth | ★ 53.29 | 7.02 |
| 52 Week Low | $1.03 | $22.68 |
| 52 Week High | $11.20 | $46.91 |
Technical Indicators
Market Signals| Indicator | TNGX | LOB |
|---|---|---|
| Relative Strength Index (RSI) | 48.99 | 63.06 |
| Support Level | $8.88 | $32.63 |
| Resistance Level | $10.22 | $33.30 |
| Average True Range (ATR) | 0.69 | 0.97 |
| MACD | -0.13 | 0.37 |
| Stochastic Oscillator | 22.04 | 94.55 |
Price Performance
Historical ComparisonAbout TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About LOB Live Oak Bancshares Inc.
Live Oak Bancshares Inc operates as the bank holding company for the Live Oak Banking Company. The company specializes in lending and deposit-related services to small businesses nationwide. The company identifies and extends lending to credit-worthy borrowers both within specific industries, also called verticals, through expertise within those industries, and more broadly to select borrowers outside of those industries. A portion of the loans originated by the Bank are partially guaranteed by the Small Business Administration under the 7(a) Loan Program and the U.S. Department of Agriculture Rural Energy for America Program, Water and Environmental Program, Business and Industry and Community Facilities loan programs.